• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经冠状窦内逆行减容术治疗难治性心绞痛患者心肌对改善灌注储备反应的特征跟踪和绘图分析:一项 CMR 研究。

Feature tracking and mapping analysis of myocardial response to improved perfusion reserve in patients with refractory angina treated by coronary sinus Reducer implantation: a CMR study.

机构信息

Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy.

School of Medicine, Vita-Salute San Raffaele University, Via Olgettina 58, 20132, Milan, Italy.

出版信息

Int J Cardiovasc Imaging. 2021 Jan;37(1):291-303. doi: 10.1007/s10554-020-01964-9. Epub 2020 Aug 28.

DOI:10.1007/s10554-020-01964-9
PMID:32860122
Abstract

Coronary sinus (CS) Reducer implantation improves myocardial perfusion and symptoms in patients with debilitating refractory angina. Its impact on myocardial remodeling remain uncertain. Aim of the present study was to assess possible impact of CS Reducer on myocardial systolic-diastolic deformation and microstructural remodeling, as assessed through cardiac magnetic resonance (CMR) feature tracking and mapping analysis. Twenty-eight consecutive patients with refractory angina underwent multiparametric stress CMR before and 4 months after CS Reducer implantation. Eight patients were excluded (6 for absence of inducible ischemia, 2 for artifacts). Modifications in 3D systo-diastolic myocardial deformation were evaluated using feature tracking analysis on rest cine images. Myocardial microstructural remodeling was assessed by native T1 mapping, cellular and matrix volume and extracellular volume fraction (ECV). Collaterally, the percentage of ischemic myocardium (ischemic burden %) and the myocardial perfusion reserve index (MPRI) were measured. After CS Reducer implantation, myocardial contractility improved (ejection fraction rose from 61 to 67%; p = 0.0079), along with longitudinal (from - 16 to - 19%; p = 0.0192) and circumferential strain (from - 18 to - 21%; p = 0.0017). Peak diastolic radial, circumferential and longitudinal strain rate did not change (p > 0.05), and no changes in native T1, ECV, cellular and matrix volume were observed. Myocardial perfusion improved, with a reduction of ischemic burden (13-11%; p = 0.0135), and recovery of intramural perfusion balance in segments with baseline ischemia (MPRi endocardial/epicardial ratio from 0.67 to 0.96; p = 0.0107). CS Reducer improves myocardial longitudinal and circumferential strain, without microstructural remodeling and no impact on diastolic proprieties.

摘要

冠状窦(CS)减容术可改善衰弱性难治性心绞痛患者的心肌灌注和症状。但其对心肌重构的影响尚不确定。本研究旨在通过心脏磁共振(CMR)特征跟踪和映射分析评估 CS 减容术对心肌收缩-舒张变形和微观结构重构的可能影响。28 例难治性心绞痛患者在 CS 减容术植入前和植入后 4 个月进行多参数应激 CMR 检查。排除 8 例患者(6 例为无诱发性缺血,2 例为伪影)。使用静息电影图像上的特征跟踪分析评估 3D 收缩-舒张期心肌变形的变化。通过原生 T1 映射、细胞和基质体积以及细胞外容积分数(ECV)评估心肌微观结构重构。此外,还测量了缺血心肌的百分比(缺血负担百分比[IB%])和心肌血流储备指数(MPRI)。CS 减容术植入后,心肌收缩力改善(射血分数从 61%增加到 67%;p=0.0079),同时纵向(从-16%增加到-19%;p=0.0192)和环向应变(从-18%增加到-21%;p=0.0017)也增加。峰值舒张径向、环向和纵向应变率没有变化(p>0.05),且原生 T1、ECV、细胞和基质体积无变化。心肌灌注改善,缺血负担减少(13%-11%;p=0.0135),并且基线缺血节段的腔内灌注平衡恢复(MPRi 心内膜/心外膜比值从 0.67 增加到 0.96;p=0.0107)。CS 减容术可改善心肌的纵向和环向应变,而不会引起微观结构重构,也不会影响舒张特性。

相似文献

1
Feature tracking and mapping analysis of myocardial response to improved perfusion reserve in patients with refractory angina treated by coronary sinus Reducer implantation: a CMR study.经冠状窦内逆行减容术治疗难治性心绞痛患者心肌对改善灌注储备反应的特征跟踪和绘图分析:一项 CMR 研究。
Int J Cardiovasc Imaging. 2021 Jan;37(1):291-303. doi: 10.1007/s10554-020-01964-9. Epub 2020 Aug 28.
2
The impact of the coronary sinus reducer upon left ventricular function in patients with refractory angina pectoris.冠状窦减少器对难治性心绞痛患者左心室功能的影响。
Catheter Cardiovasc Interv. 2020 May 1;95(6):1104-1108. doi: 10.1002/ccd.28408. Epub 2019 Aug 2.
3
Coronary Sinus Reducer Implantation to Reduce the Ischemic Burden in Refractory Angina.植入冠状静脉窦减压器以减轻顽固性心绞痛的缺血负担。
JACC Cardiovasc Interv. 2019 Jan 28;12(2):e11-e13. doi: 10.1016/j.jcin.2018.09.032. Epub 2018 Nov 15.
4
A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: study protocol for a randomized controlled trial.一项针对难治性心绞痛患者的冠状动脉窦减压器安全性和有效性的 II 期、假对照、双盲研究:一项随机对照试验的研究方案。
Trials. 2013 Feb 15;14:46. doi: 10.1186/1745-6215-14-46.
5
Coronary sinus reducer implantation in the middle cardiac vein for the treatment of refractory angina.冠状窦缩窄器在心脏中静脉植入治疗难治性心绞痛。
Catheter Cardiovasc Interv. 2020 Mar 1;95(4):718-721. doi: 10.1002/ccd.28580. Epub 2019 Nov 13.
6
The impact of coronary sinus narrowing on diastolic function in patients with refractory angina.冠状静脉窦狭窄对难治性心绞痛患者舒张功能的影响。
Int J Cardiol. 2019 Sep 15;291:8-12. doi: 10.1016/j.ijcard.2019.03.041. Epub 2019 Mar 21.
7
Coronary sinus reducer for the treatment of chronic refractory angina pectoris-results of the preclinical safety and feasibility study.用于治疗慢性难治性心绞痛的冠状窦减容装置——临床前安全性和可行性研究结果。
Catheter Cardiovasc Interv. 2018 Dec 1;92(7):1274-1282. doi: 10.1002/ccd.27709. Epub 2018 Sep 30.
8
Coronary sinus size and ischemia improvement after reducer implantation; "one size to fit them all?".减少器植入术后冠状窦大小与缺血改善:“一种尺寸适合所有人?”
Catheter Cardiovasc Interv. 2021 Sep;98(3):E365-E369. doi: 10.1002/ccd.29699. Epub 2021 Apr 14.
9
Interdependence between myocardial deformation and perfusion in patients with T2DM and HFpEF: a feature-tracking and stress perfusion CMR study.2 型糖尿病合并 HFpEF 患者心肌变形与灌注的相互关系:特征追踪和应激灌注 CMR研究。
Cardiovasc Diabetol. 2024 Aug 16;23(1):303. doi: 10.1186/s12933-024-02380-2.
10
Combined Assessment of Stress Myocardial Perfusion Cardiovascular Magnetic Resonance and Flow Measurement in the Coronary Sinus Improves Prediction of Functionally Significant Coronary Stenosis Determined by Fractional Flow Reserve in Multivessel Disease.联合评估应激心肌灌注心血管磁共振和冠状窦血流测量可提高多血管病变中通过血流储备分数测定的功能性显著冠状动脉狭窄的预测。
J Am Heart Assoc. 2018 Jan 26;7(3):e007736. doi: 10.1161/JAHA.117.007736.

引用本文的文献

1
Segmental redistribution of myocardial blood flow after coronary sinus reducer implantation demonstrated by quantitative perfusion cardiovascular magnetic resonance.冠状动脉窦缩窄器植入后心肌血流的节段性再分布:定量灌注心血管磁共振成像显示
J Cardiovasc Magn Reson. 2025 Feb 26;27(1):101868. doi: 10.1016/j.jocmr.2025.101868.
2
Focusing on microvascular function in heart failure with preserved ejection fraction.关注射血分数保留的心力衰竭中的微血管功能。
Heart Fail Rev. 2025 May;30(3):493-503. doi: 10.1007/s10741-024-10479-7. Epub 2025 Jan 13.
3
Coronary Sinus Reducer Therapy for Refractory Angina and its Role in Modern Interventional Practice: A Contemporary Review.

本文引用的文献

1
Coronary Sinus Reducer and Left Ventricular Function.
Can J Cardiol. 2020 Apr;36(4):474-475. doi: 10.1016/j.cjca.2019.12.026. Epub 2020 Jan 3.
2
Frailty in patients undergoing TAVI: how can we measure it?
EuroIntervention. 2019 Oct 20;15(8):652-655. doi: 10.4244/EIJV15I8A120.
3
Patterns of Regional Myocardial Perfusion Following Coronary Sinus Reducer Implantation: Insights by Stress Cardiac Magnetic Resonance.冠状动脉窦缩窄器植入术后局部心肌灌注模式:应力心脏磁共振成像的见解
Circ Cardiovasc Imaging. 2019 Sep;12(9):e009148. doi: 10.1161/CIRCIMAGING.119.009148. Epub 2019 Aug 27.
4
冠状动脉窦减容术治疗顽固性心绞痛及其在现代介入治疗中的作用:当代综述
Interv Cardiol. 2024 Jul 9;19:e11. doi: 10.15420/icr.2023.45. eCollection 2024.
4
The Non-Invasive Diagnosis of Chronic Coronary Syndrome: A Focus on Stress Computed Tomography Perfusion and Stress Cardiac Magnetic Resonance.慢性冠状动脉综合征的非侵入性诊断:聚焦于负荷计算机断层扫描灌注和负荷心脏磁共振成像
J Clin Med. 2023 May 31;12(11):3793. doi: 10.3390/jcm12113793.
5
Advanced cardiac imaging in athlete's heart: unravelling the grey zone between physiologic adaptation and pathology.运动员心脏的高级心脏影像学:揭开生理性适应与病理性之间的灰色地带。
Radiol Med. 2021 Dec;126(12):1518-1531. doi: 10.1007/s11547-021-01411-2. Epub 2021 Aug 22.
6
Stress CMR in Known or Suspected CAD: Diagnostic and Prognostic Role.已知或疑似 CAD 患者的压力心脏磁共振:诊断和预后作用。
Biomed Res Int. 2021 Jan 14;2021:6678029. doi: 10.1155/2021/6678029. eCollection 2021.
7
Coronary sinus reducer transfemoral extraction after intraprocedural device migration: A case report.术中装置移位后经股静脉取出冠状窦封堵器:一例报告
Clin Case Rep. 2020 Nov 24;9(1):386-390. doi: 10.1002/ccr3.3538. eCollection 2021 Jan.
Incomplete coronary sinus reducer endothelialization as potential mechanism of clinical failure.
Catheter Cardiovasc Interv. 2020 Oct 1;96(4):E493-E494. doi: 10.1002/ccd.28417. Epub 2019 Aug 4.
5
The impact of coronary sinus narrowing on diastolic function in patients with refractory angina.冠状静脉窦狭窄对难治性心绞痛患者舒张功能的影响。
Int J Cardiol. 2019 Sep 15;291:8-12. doi: 10.1016/j.ijcard.2019.03.041. Epub 2019 Mar 21.
6
Two-dimensional and three-dimensional cardiac magnetic resonance feature-tracking myocardial strain analysis in acute myocarditis patients with preserved ejection fraction.二维和三维心脏磁共振特征追踪心肌应变分析在射血分数保留的急性心肌炎患者中的应用
Int J Cardiovasc Imaging. 2019 Jun;35(6):1101-1109. doi: 10.1007/s10554-019-01588-8. Epub 2019 Mar 30.
7
Coronary Sinus Reducer implantation improves symptoms, ischaemia and physical capacity in patients with refractory angina unsuitable for myocardial revascularisation: a single-centre experience.冠状动脉窦减容术改善了不适宜进行心肌血运重建的难治性心绞痛患者的症状、缺血和体力活动能力:单中心经验。
EuroIntervention. 2018 Jul 20;14(4):e452-e458. doi: 10.4244/EIJ-D-18-00102.
8
Reverse Myocardial Remodeling Following Valve Replacement in Patients With Aortic Stenosis.主动脉瓣狭窄患者瓣膜置换术后的心肌重构逆转。
J Am Coll Cardiol. 2018 Feb 27;71(8):860-871. doi: 10.1016/j.jacc.2017.12.035.
9
Is Global Longitudinal Strain a Superior Parameter for Predicting Outcome After Myocardial Infarction?整体纵向应变是预测心肌梗死后预后的更优参数吗?
JACC Cardiovasc Imaging. 2018 Oct;11(10):1458-1460. doi: 10.1016/j.jcmg.2017.11.005. Epub 2017 Dec 13.
10
Reference ranges for three-dimensional feature tracking cardiac magnetic resonance: comparison with two-dimensional methodology and relevance of age and gender.三维特征跟踪心脏磁共振的参考范围:与二维方法的比较以及年龄和性别的相关性
Int J Cardiovasc Imaging. 2018 May;34(5):761-775. doi: 10.1007/s10554-017-1277-x. Epub 2017 Nov 27.